Biotech entity
Every one of those 3 sits in a single category, pharma. Source depth averages 2.7 original sources per story, versus 4.2 across the same-window beat baseline. AGI is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories.
Last mentioned: Feb 22, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 3 sits in a single category, pharma. Source depth averages 2.7 original sources per story, versus 4.2 across the same-window beat baseline. AGI is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories. The 7 average consequence score is above the beat benchmark of 6.3 in the same window. India AI Impact Summit 2026 appears in 3 tracked Biotech stories published from February 18, 2026 through February 19, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 40 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering India AI Impact Summit 2026. Shared-story counts are live from our verified record — not editorial picks.
The India AI Impact Summit 2026 in New Delhi is showcasing a paradigm shift in healthcare delivery, focusing on AI-powered diagnostics to bridge the rural-urban divide. Experts emphasize that these technologies are critical to making quality care affordable across the Global South.
At the India AI Impact Summit 2026, Minister Ashwini Vaishnaw highlighted a growing global consensus on mitigating AI risks while prioritizing healthcare as a core sector for AI deployment. This shift signals a move toward impact-driven, regulated AI applications that could transform drug discovery and diagnostics.
Source: moneycontrol.com · businesstoday.in
Google DeepMind CEO Demis Hassabis predicts Artificial General Intelligence (AGI) could arrive within five to eight years, ushering in a 'golden era of science' for drug discovery. While the timeline suggests a radical acceleration of biological engineering, Hassabis issued urgent warnings regarding biosecurity risks as AI systems gain autonomous capabilities.
Source: freepressjournal.in · moneycontrol.com
India AI Impact Summit 2026 is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
